POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 131 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2023. The put-call ratio across all filers is 128.31 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,000,000 | $27,180,000 | 5.32% |
| Velan Capital Investment Management LP | 342,936 | $3,107,000 | 2.88% |
| JOHNSON & JOHNSON | 1,000,000 | $9,060,000 | 2.81% |
| BVF INC/IL | 10,563,748 | $95,707,557 | 2.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $8,630,937 | 1.35% |
| Deep Track Capital, LP | 2,781,565 | $25,200,979 | 1.17% |
| Pier Capital, LLC | 879,169 | $7,965,271 | 1.14% |
| Boxer Capital, LLC | 2,500,000 | $22,650 | 1.05% |
| Avidity Partners Management LP | 1,671,800 | $15,146,508 | 0.53% |
| Eagle Health Investments LP | 306,142 | $2,773,647 | 0.52% |
| PORTLAND INVESTMENT COUNSEL INC. | 113,300 | $1,026 | 0.51% |
| Nantahala Capital Management | 572,191 | $5,184,050 | 0.50% |
| PFM Health Sciences, LP | 1,299,491 | $11,773,388 | 0.46% |
| Onex Canada Asset Management Inc. | 772,905 | $7,002,519 | 0.42% |
| AlphaCentric Advisors LLC | 70,000 | $634,200 | 0.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 93,700 | $848,922 | 0.26% |
| MOODY ALDRICH PARTNERS LLC | 145,442 | $1,317,705 | 0.26% |
| Bellevue Group AG | 1,256,197 | $11,381,145 | 0.16% |
| FIRETHORN WEALTH PARTNERS, LLC | 22,405 | $202,989 | 0.15% |
| Baskin Financial Services Inc. | 132,990 | $1,205 | 0.12% |
External links
This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q2 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.